EnGeneIC
PrivateLast Round
Crowdfunding
Aug 1, 2021
Total Funding Raised
$17.17M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
EnGeneIC is a clinical-stage biopharmaceutical company that has developed a proprietary nanocell technology for the targeted delivery of chemotherapeutics and functional nucleic acids for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EnGeneIC Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
EnGeneIC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Aug 1, 2021 | ||||
| Series B | Jan 6, 2015 |
Key People
Founding team and executive leadership
EnGeneIC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GRT Capital Partners | Series B |
| Foley & Lardner LLP | Series B |
| VentureCrowd | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 70% MoM.
- Oct 13, 2025
Grew 18% QoQ, from 44 to 52 employees.
EnGeneIC Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EnGeneIC's valuation, stock price, and market status.